Form 4 for KPTI Karyopharm Therapeutics Inc.
Accepted 2023-03-02 00:00:00 ET · period of report 2023-02-28 · accession 0001209191-23-014865 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-02 | 2023-02-28 | KPTI | Mano Michael | SVP, GC, Sec | A - Grant | $0.00 | +70.0K | 153.0K | +84% | $0 | |
| 2023-03-02 | 2023-03-01 | KPTI | Mano Michael | SVP, GC, Sec | S - Sale | $3.03 | -6,878 | 146.1K | -4% | -$20.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-28 | A | A | 70,000 | $0.00 | 153,000 | D | — | — | (F1) Represents the award of restricted stock units ("RSUs") pursuant to the Karyopharm Therapeutics Inc. 2022 Equity Incentive Plan. RSUs convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis. The RSUs vest in three equal annual installments beginning February 28, 2024. |
| 2 | Common | Common Stock | 2023-03-01 | S | D | 6,878 | $3.03 | 146,122 | D | — | — |